Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · February 08, 2024

PFS Assessment of Outcomes in Patients With Metastatic Breast Cancer in Randomized Clinical Trials by Local Investigators vs Blinded Independent Central Review

European Journal of Cancer


Additional Info

European Journal of Cancer
Progression-free survival assessment by local investigators versus blinded independent central review in randomized clinical trials in metastatic breast cancer: A systematic review and meta-analysis
Eur. J. Cancer 2024 Jan 01;197(xx)113478, F Jacobs, C Molinelli, D Martins-Branco, GN Marta, M Salmon, L Ameye, M Piccart, M Lambertini, E Agostinetto, E de Azambuja

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading